_version_ 1784883269815238656
author Kurata, Keiji
James-Bott, Anna
Tye, Mark A.
Yamamoto, Leona
Samur, Mehmet K.
Tai, Yu-Tzu
Dunford, James
Johansson, Catrine
Senbabaoglu, Filiz
Philpott, Martin
Palmer, Charlotte
Ramasamy, Karthik
Gooding, Sarah
Smilova, Mihaela
Gaeta, Giorgia
Guo, Manman
Christianson, John C.
Payne, N. Connor
Singh, Kritika
Karagoz, Kubra
Stokes, Matthew E.
Ortiz, Maria
Hagner, Patrick
Thakurta, Anjan
Cribbs, Adam
Mazitschek, Ralph
Hideshima, Teru
Anderson, Kenneth C.
Oppermann, Udo
author_facet Kurata, Keiji
James-Bott, Anna
Tye, Mark A.
Yamamoto, Leona
Samur, Mehmet K.
Tai, Yu-Tzu
Dunford, James
Johansson, Catrine
Senbabaoglu, Filiz
Philpott, Martin
Palmer, Charlotte
Ramasamy, Karthik
Gooding, Sarah
Smilova, Mihaela
Gaeta, Giorgia
Guo, Manman
Christianson, John C.
Payne, N. Connor
Singh, Kritika
Karagoz, Kubra
Stokes, Matthew E.
Ortiz, Maria
Hagner, Patrick
Thakurta, Anjan
Cribbs, Adam
Mazitschek, Ralph
Hideshima, Teru
Anderson, Kenneth C.
Oppermann, Udo
author_sort Kurata, Keiji
collection PubMed
description
format Online
Article
Text
id pubmed-9902474
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99024742023-02-08 Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma Kurata, Keiji James-Bott, Anna Tye, Mark A. Yamamoto, Leona Samur, Mehmet K. Tai, Yu-Tzu Dunford, James Johansson, Catrine Senbabaoglu, Filiz Philpott, Martin Palmer, Charlotte Ramasamy, Karthik Gooding, Sarah Smilova, Mihaela Gaeta, Giorgia Guo, Manman Christianson, John C. Payne, N. Connor Singh, Kritika Karagoz, Kubra Stokes, Matthew E. Ortiz, Maria Hagner, Patrick Thakurta, Anjan Cribbs, Adam Mazitschek, Ralph Hideshima, Teru Anderson, Kenneth C. Oppermann, Udo Blood Cancer J Correction Nature Publishing Group UK 2023-02-07 /pmc/articles/PMC9902474/ /pubmed/36746923 http://dx.doi.org/10.1038/s41408-023-00793-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Kurata, Keiji
James-Bott, Anna
Tye, Mark A.
Yamamoto, Leona
Samur, Mehmet K.
Tai, Yu-Tzu
Dunford, James
Johansson, Catrine
Senbabaoglu, Filiz
Philpott, Martin
Palmer, Charlotte
Ramasamy, Karthik
Gooding, Sarah
Smilova, Mihaela
Gaeta, Giorgia
Guo, Manman
Christianson, John C.
Payne, N. Connor
Singh, Kritika
Karagoz, Kubra
Stokes, Matthew E.
Ortiz, Maria
Hagner, Patrick
Thakurta, Anjan
Cribbs, Adam
Mazitschek, Ralph
Hideshima, Teru
Anderson, Kenneth C.
Oppermann, Udo
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title_full Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title_fullStr Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title_full_unstemmed Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title_short Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
title_sort correction: prolyl-trna synthetase as a novel therapeutic target in multiple myeloma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902474/
https://www.ncbi.nlm.nih.gov/pubmed/36746923
http://dx.doi.org/10.1038/s41408-023-00793-y
work_keys_str_mv AT kuratakeiji correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT jamesbottanna correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT tyemarka correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT yamamotoleona correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT samurmehmetk correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT taiyutzu correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT dunfordjames correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT johanssoncatrine correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT senbabaoglufiliz correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT philpottmartin correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT palmercharlotte correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT ramasamykarthik correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT goodingsarah correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT smilovamihaela correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT gaetagiorgia correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT guomanman correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT christiansonjohnc correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT paynenconnor correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT singhkritika correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT karagozkubra correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT stokesmatthewe correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT ortizmaria correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT hagnerpatrick correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT thakurtaanjan correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT cribbsadam correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT mazitschekralph correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT hideshimateru correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT andersonkennethc correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma
AT oppermannudo correctionprolyltrnasynthetaseasanoveltherapeutictargetinmultiplemyeloma